Cargando…
Looking at New Unexpected Disease Targets in LMNA-Linked Lipodystrophies in the Light of Complex Cardiovascular Phenotypes: Implications for Clinical Practice
Variants in LMNA, encoding A-type lamins, are responsible for laminopathies including muscular dystrophies, lipodystrophies, and progeroid syndromes. Cardiovascular laminopathic involvement is classically described as cardiomyopathy in striated muscle laminopathies, and arterial wall dysfunction and...
Autores principales: | Mosbah, Héléna, Vatier, Camille, Boccara, Franck, Jéru, Isabelle, Lascols, Olivier, Vantyghem, Marie-Christine, Fève, Bruno, Donadille, Bruno, Sarrazin, Elisabeth, Benabbou, Sophie, Inamo, Jocelyn, Ederhy, Stéphane, Cohen, Ariel, Neraud, Barbara, Richard, Pascale, Picard, Fabien, Christin-Maitre, Sophie, Redheuil, Alban, Wahbi, Karim, Vigouroux, Corinne |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7140635/ https://www.ncbi.nlm.nih.gov/pubmed/32245113 http://dx.doi.org/10.3390/cells9030765 |
Ejemplares similares
-
Molecular and Cellular Bases of Lipodystrophy Syndromes
por: Zammouri, Jamila, et al.
Publicado: (2022) -
Metreleptin therapy in LMNA-linked lipodystrophies
por: Vatier, Camille, et al.
Publicado: (2015) -
Diagnostic Challenge in PLIN1-Associated Familial Partial Lipodystrophy
por: Jéru, Isabelle, et al.
Publicado: (2019) -
Dunnigan lipodystrophy syndrome: French National Diagnosis and Care Protocol (PNDS; Protocole National de Diagnostic et de Soins)
por: Mosbah, H., et al.
Publicado: (2022) -
Therapeutic indications and metabolic effects of metreleptin in patients with lipodystrophy syndromes: Real‐life experience from a national reference network
por: Mosbah, Héléna, et al.
Publicado: (2022)